Arrowhead Pharmaceuticals Inc (ARWR)

Total asset turnover

		Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Revenue (ttm)	US$ in thousands	3,551	14,386	25,053	166,263	225,258	245,998	267,743	278,338	243,231	249,939	263,418	144,424	138,288	107,638	89,123	79,841	87,993	123,653	138,974	163,593
Total assets	US$ in thousands	1,139,800	883,759	955,150	626,286	765,552	795,856	891,308	891,489	691,939	751,782	703,575	638,539	710,148	734,927	756,795	499,251	522,504	555,728	561,076	587,602
Total asset turnover		0.00	0.02	0.03	0.27	0.29	0.31	0.30	0.31	0.35	0.33	0.37	0.23	0.19	0.15	0.12	0.16	0.17	0.22	0.25	0.28

September 30, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $3,551K ÷ $1,139,800K
= 0.00

Arrowhead Pharmaceuticals Inc's total asset turnover has shown fluctuations over the last few quarters. The total asset turnover is an indication of how effectively the company is utilizing its assets to generate revenue. A higher total asset turnover ratio typically indicates better asset utilization.

Looking at the data, we can see that the total asset turnover ratio has ranged from as low as 0.00 to as high as 0.37 over the past few quarters. In recent quarters, the total asset turnover ratio has been relatively stable, ranging between 0.27 and 0.37, which suggests that the company has been able to generate more revenue relative to its total assets during these periods.

However, the total asset turnover ratio was considerably lower in some earlier periods, such as in Q3 2021 and Q4 2021, where it was below 0.25. This may indicate that the company was less efficient in utilizing its assets to generate revenue during those quarters.

Overall, Arrowhead Pharmaceuticals Inc's total asset turnover has shown some variability, but the recent trend indicates improved efficiency in generating revenue relative to its total assets. Further analysis and comparison with industry benchmarks could provide additional insights into the company's asset utilization efficiency.